Oxytocin Infusion and the Duration of the Active Phase of Labor in Nulliparous Women with Term Pregnancies

Document Type : Original Article (s)

Authors

1 Medical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Associated Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor of Obstetrics and Gynecology, Department of Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/jims.v43.i832.1199

Abstract

Background: This study aimed to evaluate the effect of oxytocin administration on the duration of the active phase of labor in nulliparous women with term pregnancies.
Methods: In this double-blind clinical trial, 100 pregnant women, candidates for elective normal vaginal delivery (NVD) and who had entered the active phase of labor were randomly divided into two groups of 50. In the first group, oxytocin was infused with normal saline and in the second group, normal saline was infused alone during the active phase of labor. The time from 6 to 10 cm cervical dilation, the time from 6 cm dilation to delivery, and labor outcomes were recorded and compared between the two groups.
Findings: The mean duration from 6 cm to 10 cm cervical dilation was 178.20 ± 32.54 minutes in the intervention group and 197.30 ± 38.71 minutes in the control group, with no significant difference between the groups (P = 0.44). The mean duration from 6 cm cervical dilation to delivery was 187.80 ± 96.25 minutes in the intervention group and 204.00 ± 110.34 minutes in the control group, with a significant difference between the groups (P = 0.009).
Conclusion: Continuing oxytocin infusion during the active phase of labor in nulliparous women induced with oxytocin shortened the duration of the active phase and may help promote NVD by increasing maternal satisfaction.

Highlights

Azar Danesh Shahraki: Google Scholar, PubMed

Amirreza Farhadian Dehkordi: Google Scholar, PubMed

Minoo Movahedi: Google Scholar, PubMed

Azam Zafarbakhsh: Google Scholar, PubMed

Keywords

Main Subjects


  1. Marconi AM. Recent advances in the induction of labor. F1000Res 2019; 8: F1000-aculty.
  2. Moore LE, Rayburn WF. Elective Induction of Labor. Clin Obstet Gynecol 2006; 49(3): 698-704.
  3. Lueth GD, Kebede A, Medhanyie AA. Prevalence, outcomes and associated factors of labor induction among women delivered at public hospitals of MEKELLE town-(a hospital based cross sectional study). BMC Pregnancy Childbirth 2020; 20(1): 203.
  4. Kim HI, Choo SP, Han SW, Kim EH. Benefits and risks of induction of labor at 39 or more weeks in uncomplicated nulliparous women: a retrospective, observational study. Obstet Gynecol Sci 2018; 62(1): 19-26.
  5. Swamy GK. Current methods of labor induction. Semin Perinatol 2012; 36(5): 348-52.
  6. Smith JG, Merrill DC. Oxytocin for induction of labor. Clin Obstet Gynecol 2006; 49(3): 594-608.
  7. Hidalgo-Lopezosa P, Hidalgo-Maestre M, Rodríguez-Borrego MA. Labor stimulation with oxytocin: effects on obstetrical and neonatal outcomes. Rev Lat Am Enfermagem 2016; 24: e2744.
  8. Acharya T, Devkota R, Bhattarai B, Acharya R. Outcome of misoprostol and oxytocin in induction of labour. SAGE Open Med 2017; 5: 2050312117700809.
  9. Tesemma MG, Sori DA, Gemeda DH. High Dose and Low Dose Oxytocin Regimens as Determinants of Successful Labor Induction: A multicenter comparative study. BMC Pregnancy Childbirth 2020; 20(1): 232.
  10. Østborg TB, Romundstad PR, Eggebø TM. Duration of the active phase of labor in spontaneous and induced labors. Acta Obstet Gynecol Scand 2017; 96(1): 120-7.
  11. Saccone G, Ciardulli A, Baxter JK, Quiñones JN, Diven LC, Pinar B, et al. Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis. Obstet Gynecol 2017; 130(5): 1090-6.
  12. Sargunam PN, Bak LL, Tan PC, Vallikkannu N, Noor Azmi MA, Zaidi SN, et al. Induction of labor compared to expectant management in term nulliparas with a latent phase of labor of more than 8 hours: a randomized trial. BMC Pregnancy Childbirth 2019; 19(1): 493.
  13. Bor P, Ledertoug S, Boie S, Knoblauch NO, Stornes I. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial. BJOG 2016; 123(1): 129-35.
  14. Chopra S, SenGupta SK, Jain V, Kumar P. Stopping oxytocin in active labor rather than continuing it until delivery: a viable option for the induction of labor. Oman Med J 2015; 30(5): 320-5.